Treatment Resistant Alcohol Use Disorder

被引:0
|
作者
Patterson Silver Wolf, David A. [1 ]
Dulmus, Catherine N. [2 ]
Wilding, Gregory E. [3 ]
Yu, Jihnhee [3 ]
Barczykowski, Amy L. [3 ]
Shi, Tiange [3 ]
Diebold, Josal R. [2 ]
Harvey, Steven J. [4 ]
Tomasello, Nicole M. [4 ]
Linn, Braden K. [2 ]
机构
[1] Washington Univ, Brown Sch, St Louis, MO 63110 USA
[2] Univ Buffalo, Sch Social Work, 221 Parker Hall, Buffalo, NY 14214 USA
[3] Univ Buffalo, Biostat, Buffalo, NY USA
[4] Ipa Inc, Integr Partners Behav Hlth, Batavia, NY USA
关键词
Alcohol use disorder; treatment recycling; recidivism; treatment resistance; risk factors; treatment-as-usual; NATIONAL EPIDEMIOLOGIC SURVEY; DEPRESSION; NALTREXONE; DRINKING; RISK;
D O I
10.1080/07347324.2021.1989994
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Despite existing interventions that have shown some promise for people with alcohol use disorder (AUD), there is a sizable number of patients that fail to respond to or complete treatment. In the current study, we analyzed data from the Treatment Episode Data Set (TEDS) to create profiles that indicate who may be more likely to resist treatment-as-usual. For the analysis, chi-square and logistic regression were used to associate personal characteristics with being at high and low risk of treatment resistance. Characteristics that put someone at higher risk of resisting treatment-as-usual include being unemployed, homelessness (or a dependent living arrangement), using daily, being male, and co-occurring mental and substance abuse disorders. The results suggest that general demographic information at patients' admission can be used to identify population groups where conventional strategies for standard AUD treatment may be insufficient. As such, the findings can help to inform, shape, and personalize treatment, leading to successful outcomes for the subgroup of individuals who will not benefit from typical AUD interventions.
引用
收藏
页码:205 / 216
页数:12
相关论文
共 50 条
  • [31] Advances in the science and treatment of alcohol use disorder
    Witkiewitz, K.
    Litten, R. Z.
    Leggio, L.
    SCIENCE ADVANCES, 2019, 5 (09):
  • [32] Editorial: Baclofen in the Treatment of Alcohol Use Disorder
    de Beaurepaire, Renaud
    Heydtmann, Mathis
    Agabio, Roberta
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [33] Noradrenergic targets for the treatment of alcohol use disorder
    Haass-Koffler, Carolina L.
    Swift, Robert M.
    Leggio, Lorenzo
    PSYCHOPHARMACOLOGY, 2018, 235 (06) : 1625 - 1634
  • [34] Repurposing Tigecycline for the Treatment of Alcohol Use Disorder
    Oliveros, Alfredo
    Choi, Doo-Sup
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 (03) : 497 - 500
  • [35] Expanding Treatment Options for Alcohol Use Disorder
    Uscher-Pines, Lori
    Lin, Kevin
    Busch, Alisa B.
    JAMA HEALTH FORUM, 2024, 5 (08):
  • [36] TREATMENT INTERVENTIONS FOR WOMEN WITH ALCOHOL USE DISORDER
    McCrady, Barbara S.
    Epstein, Elizabeth E.
    Fokas, Kathryn F.
    ALCOHOL RESEARCH-CURRENT REVIEWS, 2020, 40 (02):
  • [37] Sobering Perspectives on the Treatment of Alcohol Use Disorder
    Yaseen, Wid
    Mong, Jonathan
    Zipursky, Jonathan
    JAMA NETWORK OPEN, 2024, 7 (03)
  • [38] Pharmacological Treatment Options for Alcohol Use Disorder
    Evren, Cuneyt
    Bozkurt, Muge
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2015, 28 (04): : 283 - 300
  • [39] Neurobeachin, a promising target for use in the treatment of alcohol use disorder
    Carlson, Verginia C. Cuzon
    Aylwin, Carlos F.
    Carlson, Timothy L.
    Ford, Matthew
    Mesnaoui, Houda
    Lomniczi, Alejandro
    Ferguson, Betsy
    Cervera-Juanes, Rita P.
    ADDICTION BIOLOGY, 2022, 27 (01)
  • [40] The use of chemogenetic approaches in alcohol use disorder research and treatment
    Cheng, Yifeng
    Wang, Jun
    ALCOHOL, 2019, 74 : 39 - 45